These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8764823)

  • 1. Expression of cDNA-encoded human acid alpha-glucosidase in milk of transgenic mice.
    Bijvoet AG; Kroos MA; Pieper FR; de Boer HA; Reuser AJ; van der Ploeg AT; Verbeet MP
    Biochim Biophys Acta; 1996 Aug; 1308(2):93-6. PubMed ID: 8764823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human acid alpha-glucosidase: high level production in mouse milk, biochemical characteristics, correction of enzyme deficiency in GSDII KO mice.
    Bijvoet AG; Kroos MA; Pieper FR; Van der Vliet M; De Boer HA; Van der Ploeg AT; Verbeet MP; Reuser AJ
    Hum Mol Genet; 1998 Oct; 7(11):1815-24. PubMed ID: 9736785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II.
    Bijvoet AG; Van Hirtum H; Kroos MA; Van de Kamp EH; Schoneveld O; Visser P; Brakenhoff JP; Weggeman M; van Corven EJ; Van der Ploeg AT; Reuser AJ
    Hum Mol Genet; 1999 Nov; 8(12):2145-53. PubMed ID: 10545593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Pompe's disease with recombinant enzymes].
    Van Hove JL
    Verh K Acad Geneeskd Belg; 1998; 60(4):347-57. PubMed ID: 9883081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human acid alpha-glucosidase corrects acid alpha-glucosidase-deficient human fibroblasts, quail fibroblasts, and quail myoblasts.
    Yang HW; Kikuchi T; Hagiwara Y; Mizutani M; Chen YT; Van Hove JL
    Pediatr Res; 1998 Mar; 43(3):374-80. PubMed ID: 9505277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterisation of a recombinant, precursor form of lysosomal acid alpha-glucosidase.
    Fuller M; Van der Ploeg A; Reuser AJ; Anson DS; Hopwood JJ
    Eur J Biochem; 1995 Dec; 234(3):903-9. PubMed ID: 8575451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle.
    Pauly DF; Johns DC; Matelis LA; Lawrence JH; Byrne BJ; Kessler PD
    Gene Ther; 1998 Apr; 5(4):473-80. PubMed ID: 9614571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFR(neg) cell line.
    Martiniuk F; Chen A; Donnabella V; Arvanitopoulos E; Slonim AE; Raben N; Plotz P; Rom WN
    Biochem Biophys Res Commun; 2000 Oct; 276(3):917-23. PubMed ID: 11027569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acid alpha-glucosidase deficiency: Pompe's disease].
    Iwamasa T
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):686-92. PubMed ID: 3152090
    [No Abstract]   [Full Text] [Related]  

  • 10. Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe disease.
    Pauly DF; Fraites TJ; Toma C; Bayes HS; Huie ML; Hirschhorn R; Plotz PH; Raben N; Kessler PD; Byrne BJ
    Hum Gene Ther; 2001 Mar; 12(5):527-38. PubMed ID: 11268285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-mediated uptake of acid alpha-glucosidase corrects lysosomal glycogen storage in cultured skeletal muscle.
    Van der Ploeg AT; Loonen MC; Bolhuis PA; Busch HM; Reuser AJ; Galjaard H
    Pediatr Res; 1988 Jul; 24(1):90-4. PubMed ID: 2970619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
    Raben N; Fukuda T; Gilbert AL; de Jong D; Thurberg BL; Mattaliano RJ; Meikle P; Hopwood JJ; Nagashima K; Nagaraju K; Plotz PH
    Mol Ther; 2005 Jan; 11(1):48-56. PubMed ID: 15585405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral transfer of acid alpha-glucosidase cDNA to enzyme-deficient myoblasts results in phenotypic spread of the genotypic correction by both secretion and fusion.
    Zaretsky JZ; Candotti F; Boerkoel C; Adams EM; Yewdell JW; Blaese RM; Plotz PH
    Hum Gene Ther; 1997 Sep; 8(13):1555-63. PubMed ID: 9322088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease.
    Van Hove JL; Yang HW; Wu JY; Brady RO; Chen YT
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):65-70. PubMed ID: 8552676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate-remodelled acid alpha-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice.
    Zhu Y; Li X; McVie-Wylie A; Jiang C; Thurberg BL; Raben N; Mattaliano RJ; Cheng SH
    Biochem J; 2005 Aug; 389(Pt 3):619-28. PubMed ID: 15839836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen Storage Disease type II: genetic and biochemical analysis of novel mutations in infantile patients from Turkish ancestry.
    Hermans MM; Kroos MA; Smeitink JA; van der Ploeg AT; Kleijer WJ; Reuser AJ
    Hum Mutat; 1998; 11(3):209-15. PubMed ID: 9521422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a single base pair deletion (delta T525) and a C1634T missense mutation (pro545leu) on the expression of lysosomal alpha-glucosidase in patients with glycogen storage disease type II.
    Hermans MM; De Graaff E; Kroos MA; Mohkamsing S; Eussen BJ; Joosse M; Willemsen R; Kleijer WJ; Oostra BA; Reuser AJ
    Hum Mol Genet; 1994 Dec; 3(12):2213-8. PubMed ID: 7881422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.
    Van den Hout JM; Kamphoven JH; Winkel LP; Arts WF; De Klerk JB; Loonen MC; Vulto AG; Cromme-Dijkhuis A; Weisglas-Kuperus N; Hop W; Van Hirtum H; Van Diggelen OP; Boer M; Kroos MA; Van Doorn PA; Van der Voort E; Sibbles B; Van Corven EJ; Brakenhoff JP; Van Hove J; Smeitink JA; de Jong G; Reuser AJ; Van der Ploeg AT
    Pediatrics; 2004 May; 113(5):e448-57. PubMed ID: 15121988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen storage in multiple muscles of old GSD-II mice can be rapidly cleared after a single intravenous injection with a modified adenoviral vector expressing hGAA.
    Xu F; Ding E; Migone F; Serra D; Schneider A; Chen YT; Amalfitano A
    J Gene Med; 2005 Feb; 7(2):171-8. PubMed ID: 15515143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects in synthesis, phosphorylation, and maturation of acid alpha-glucosidase in glycogenosis type II.
    Reuser AJ; Kroos M; Oude Elferink RP; Tager JM
    J Biol Chem; 1985 Jul; 260(14):8336-41. PubMed ID: 3159730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.